or Try an Advanced Search...

    Benzamides Stocks List

    Symbol Grade Name % Change
    SNDX D Syndax Pharmaceuticals, Inc. -3.45
    KURA D Kura Oncology, Inc. -2.49
    EVOK F Evoke Pharma, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Medicine Cancer Solid Tumors Acute Leukemia Antiemetics Antineoplastic Drugs Blood Cancers Breast Cancer Cancer Cell Cancer Therapies Carcinoma Cell Signaling Chloroarenes Clinical Medicine Diabetes Diabetes Mellitus Disease Gastroenterology Gastrointestinal Gastrointestinal Disorders

    Related ETFs - A few ETFs which own one or more of the above listed Benzamides stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 2.48
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.26
    SBIO D ALPS Medical Breakthroughs ETF 2.21
    XBI D SPDR S&P Biotech ETF 1.74
    PTH D Invesco DWA Healthcare Momentum ETF 1.31
    View all Benzamides ETFs...
    Compare ETFs
    Compare BBC to SBIO Compare CNCR to BBC Compare CNCR to XBI

        Benzamides Stocks Recent News

        Date Stock Title
        May 8 SNDX Syndax Pharmaceuticals, Inc. (SNDX) Q1 2024 Earnings Call Transcript
        May 8 KURA 2 Incredible Growth Stocks to Buy Hand Over Fist
        May 8 KURA Kura Oncology to Participate in Bank of America Securities Healthcare Conference
        May 8 SNDX Syndax Pharmaceuticals GAAP EPS of -$0.85 beats by $0.12
        May 8 SNDX Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
        May 7 SNDX Syndax Pharmaceuticals Q1 2024 Earnings Preview
        May 7 KURA Kura Oncology: Balancing Act Of Promise And Pragmatism
        May 6 KURA Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript
        May 4 KURA Kura Oncology, Inc. (KURA) Q1 2024 Earnings Call Transcript
        May 3 KURA Kura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...
        May 2 KURA Kura Oncology GAAP EPS of -$0.59 misses by $0.03
        May 2 KURA Kura Oncology Reports First Quarter 2024 Financial Results
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Medicine Cancer Solid Tumors Acute Leukemia Antiemetics Antineoplastic Drugs Blood Cancers Breast Cancer Cancer Cell Cancer Therapies Carcinoma Cell Signaling Chloroarenes Clinical Medicine Diabetes Diabetes Mellitus Disease Gastroenterology Gastrointestinal Gastrointestinal Disorders
        Benzamides

        Benzamide is an off-white solid with the chemical formula of C6H5CONH2. It is a derivative of benzoic acid. It is slightly soluble in water, and soluble in many organic solvents.

        More about Benzamides
        Browse All Tags